Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH Long-term Investments

Investments the company intends to hold for more than a year.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

Long-term Investments · Q2 FY2026 · quarter ended Jun 2026

Long-term investments remains negative

Q2 FY2026 long-term investments was $0, compared with $32.2M a year earlier. Over 3 fiscal years it compounded at +33.4% a year.

Context

  • Long-term investments amounted to 0.0% of total assets at the end of Q2 FY2026, down 0.1 pp from a year earlier.
  • Long-term investments increased in 2 of the last 3 fiscal years.

What to watch

Whether long-term investments keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$39.4M-46.2% YoY
Year agoJun 2025
$32.2M-100.0% since
Long-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-46.2%——
3-year CAGR+33.4%——
5-year CAGR——
10-year CAGR——

Long-term Investments history

USD · from the balance sheet

Latest · FY2025
39.4M USD
Year-over-year change
-46.2%
4-year CAGR
+9.3%

Long-term Investments vs competitors

How ZBH compares with its peers on the latest reported figures

  • Peers report in different currencies, so long-term investments is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -100.0% is the 6th highest of 7, against a peer median of +142.1%.
  • Long-term investments amounts to 0.0% of total assets for ZBH, versus a peer median of 1.4%.
ZBH Competitors
Long-term Investments for ZBH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BSXBoston Scientific CorporationJun 2026$2.25B USD+258.6%+27.4%5.0%
MDTMedtronic plcJul 2026$1.31B USD——1.4%
PHGKoninklijke Philips N.V.Jun 2026€862M EUR+25.7%-10.7%3.2%
EWEdwards Lifesciences CorporationJun 2026$244.1M USD-18.2%-14.5%1.8%
SNNSmith & Nephew plcDec 2025$151M USD+843.8%+37.6%1.4%
SYKStryker CorporationJun 2026$81M USD+2600.0%-71.9%0.2%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$0 USD-100.0%+33.4%0.0%
GEHCGE HealthCare Technologies Inc.Jun 2026$0 USD-100.0%—0.0%
ALGNAlign Technology, Inc.Jun 2026$0 USD——0.0%
OFIXOrthofix Medical Inc.Mar 2026$0 USD——0.0%
Peer median (excluding ZBH) —+142.1%-10.7%1.4%

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents378.1M375.7M415.8M525.5M591.9M
Short-term Investments00000
Net Receivables1.26B1.38B1.44B1.48B1.7B
Inventory2.15B2.15B2.39B2.24B2.29B
Other Current Assets772.6M324.5M366.1M430M537.2M
Total Current Assets4.89B4.43B4.61B4.67B5.12B
Property, Plant & Equipment (Net)1.84B1.87B2.06B2.05B2.21B
Goodwill8.92B8.58B8.82B8.95B9.95B
Intangible Assets5.53B5.06B4.86B4.6B4.72B
Long-term Investments27.6M16.6M31.6M73.2M39.4M
Tax Assets00000
Other Non-current Assets2.25B1.11B1.12B1.02B1.1B
Total Non-current Assets18.57B16.64B16.89B16.69B17.97B
Total Assets23.46B21.07B21.5B21.37B23.09B
Account Payables306.5M354.1M410.6M194.6M303M
Short-term Debt1.61B544.3M900M863M587.1M
Tax Payables62M38.5M61.2M00
Deferred Revenue00000
Other Current Liabilities640.5M502.8M326.1M286M382M
Total Current Liabilities3.47B2.36B2.86B2.45B2.58B
Long-term Debt5.46B5.15B4.87B5.34B6.93B
Deferred Tax Liabilities558.5M474.8M357.6M352.5M244.1M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.3B1.05B925.9M744.1M626.1M
Total Non-current Liabilities7.32B6.68B6.15B6.44B7.8B
Total Liabilities10.79B9.04B9.01B8.89B10.39B
Common Stock3.1M3.1M3.2M3.2M3.2M
Retained Earnings10.29B9.56B10.38B11.1B11.61B
Accumulated OCI(231.6M)(179.3M)(191M)(262.8M)(205.7M)
Other Stockholders Equity00000
Minority Interest5.7M6.7M7.7M8.1M8.1M
Total Equity12.67B12.03B12.48B12.48B12.71B
Total Debt7.07B5.7B5.77B6.2B7.52B
Net Debt6.69B5.32B5.35B5.68B6.93B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.